Member Info for nice1

I think the buy out of Enielle could be a good move, lets face it with the management we had and the routing we went down it was a failure, you can have the best product in the world but if you don't have the experience in selling it and getting it out there then it does nothing.

Enielle has really for years been creating a serum and not really sold anything, but has lots of science and testing behind it, when you check there website after using it the results look visible in weeks which is quite impressive, before and after pictures.

There seems to be new products also like the suncare spray coming soon at SPF 50.

from co-pilot

2016 – Founded Enielle is established in Zurich as a premium skincare startup focused on lectin‑based formulations.

2017–2020 – R&D Phase Development of the T‑Mero‑Protect® ingredient, clinical testing, and formulation refinement.

2021–2024 – Pre‑launch & soft‑launch Small‑batch production, clinical studies, website launch, limited online availability.

2025 – Limited commercial availability Product can be purchased online, but sales volume remains very low.

2026 – Acquisition by Incanthera Enielle becomes part of Incanthera’s dermatology portfolio.

Skin and Cell has basically bought a company that has done all the work, trials and testing and serum that is clinical tested, also £3 million has been spent to get Enielle to this stage.

The management team going forward needs to relook at there website, i personally think the Enielle website looks more serious, has the before and after pictures to help plus information and the Skin + Cell just comes across to focus on young girls who can not afford these prices.

Enielle comes across Elegant, luxury‑skincare energy.

Skin+CELL — comes across, Clinical, biotech

Both have a very high pricing range that is not affordable for most people out there, a lot needs to be worked on if we are going to connect and sell.

As we have a new management team, I have asked the company going forward what will be done and the company is working on interviews and POD casts out there and better communication is required.

We also need clear strategy going forward.

Will be quite exciting once we are listed, before listing we need some good news on the current drills.

Also Nick needs to get the PR full on and make sure the write up's justify what we have.

Some of the past write up's don't really do it and does not have the full and latest information which does not give out the right signals.

The below is an example and pointless, the write up needs to advise everything as per the operations updates to give new AIM investors a true idea what MDH as achieved compare to the peers.

You look at Pulsa Helium who are not producing but they have got out there on the media which has helps awareness.

Https://www.share-talk.com/mendell-helium-plc-aqse-mdh-preparing-to-join-the-aim-market/

I have sold out, I have put my funds into MDH.

Gold luck to all.

Even with a good RNS the market has not responded positively, when you look at the pattern this shares goes up and then goes back down so much, Jangada is a share watched by a lot and has the potential, but the board does not know how to promote the company and help keep the share price from dropping, frustration has been seen by many share holders and the management needs to start taking on board and be better with there communication and PR.

If not even with great grades share holders will be reluctant, we have all been there before.

Hi Larus yes you are correct and thanks I hope no further big dilutions occur so we share holders do not get diluted down.

Looking forward to the next update on the wells being worked on.

The RNS is very positive and looking for further updates.

We need some very good news before we list on to the AIM market else we could see the share prices heading down instead of up.

One thing MDH has done a lot of is issued a lot of shares through placing and warrants, I just don't want MDH to be another small cap that has gone mad on issuing share and us share holders end up paying for it.

Will MDH need funds when they list on the AIM as I think this will be quite expensive and maybe more dilution coming. not sure on this if anyone knows.

The more wells MDH can achieve in production the better we are when listing. we have a very proactive team that does not want to waste any time.

On completion, 57,611,552 new shares are due to M3 shareholders; until then, M3’s assets are not part of MDH

When will this happen.

Email from company.

We are working incredibly hard behind the scenes to try and there is activity surrounding much you have mentioned here.

It’s frustrating that things take so long, we had hoped to say much more by the time we needed to update the market.

Please know we are all working hard, it’s been the longest rollercoaster and we are all so personally, emotionally and professionally invested, we are working hard towards a next announcement with more commercial substance.

It is great to see MDH moving quickly and being very proactive, our share price does not reflex how far MDH has gone and when you compare it to other Helium explorers and producers.

Helium prices are on the rise and the sooner MDH lists on the AIM the better as there must be so many new investors waiting for this to happen and most importantly, MDH needs to acquire M3 Helium.

Before the acquisition, Mendell is essentially a shell or early‑stage explorer.

After acquiring M3, it suddenly owns:

Multiple producing wells in Kansas

A mobile PSA plant

A helium processing and sales operation

A pipeline of new wells ready for development

This transforms Mendell from a story into a revenue‑generating business.

Markets always value producers far higher than explorers.

Helium demand is rising due to:

Semiconductor manufacturing

MRI machines

Space and aerospace

Quantum computing

Meanwhile, global supply is tight.

Companies with domestic, reliable helium production get premium valuations.

M3 gives Mendell exactly that.

This link is worth listening to, MDH needs to get out there a let everyone know about them.

https://x.com/pulsarhelium/status/2040437346055651399

Let hope we get an RNS soon with more drilling results, this is over due now.

Remainder of drilling assay results expected in February 2026; as per the RNS.

The product is good, i still think the pricing should be lower so more can afford it and get it on the shelves with the big Super Markets, the awareness will expand.

I would have thought trust pilot would have had a lot more reviews, 21 at present all showing 5 star.

I did emailed the company 2 weeks back and no response.

Lets hope there is a lot going on in the back ground and we get a very good RNS when it does happen.

Whiles other Helium peers are growing in value, MDH is not getting much attention and we all know it is down to AQSE market and there silly spreads.

On the last RNS i wanted to break it down a bit as we are actually selling more helium, so i asked AI to question to get more of a understanding.

Confirmed: MDH Achieved ~10.4% Helium via Membrane Separation

The London South East RNS discussion board contains the exact wording you posted, confirming:

“Pending commissioning of its PSA, M3 Helium has utilised membrane separation units at Rost operating using the natural flowing pressure of the well and has achieved an improvement in concentration of the product gas to approximately 10.4 percent, roughly double the concentration of the native gas and thereby doubling the value of each tube trailer delivery of helium.”

🔍 What This Actually Means

✔ 1. Native helium concentration is ~5.1%

We previously saw this confirmed across multiple RNS sources.

[lse.co.uk], [stockanalysis.com], [investorsh....advfn.com]

✔ 2. Membrane separation (NOT PSA) increased output gas to 10.4%

This does not change the geological helium concentration, but it does mean:

The gas shipped to buyers is now ~10.4% helium

This is double the 5.1% native grade

Each tube‑trailer shipment is now worth twice as much

The RNS explicitly confirms both the concentration increase and value increase.

Is ~10.4% Considered World‑Class?

🌍 YES — in terms of product gas concentration.

While MDH's native reservoir grade is ~5.1%, which is good but not world‑class…

A processed helium output of ~10.4% puts their delivered product into the same range as early‑stage primary helium producers and is approaching Pulsar’s early flow test grades (5.6–8.1%). [pulsarhelium.com]

Pulsar’s absolute top-tier grades (up to 14.5%) remain rare, but:

👉 MDH now has:

Production already underway

Improved concentration via membranes to 10.4%

Higher-value shipments today

PSA still coming, which will further raise concentration (typically 70–90%)

This combination — production + significantly upgraded helium concentration — is genuinely powerful and something Pulsar does not yet have.

⭐ Bottom line:

MDH isn’t yet “world-class geology,” but its delivered helium product is now approaching world-class levels, and they are actually producing and selling helium today.

This makes MDH extremely competitive relative to its peers — and in some respects superior.

Once we dual list on the AIM, the spread will not be as bad on the AQSE.

Aim will have a lot more daily trades and gives the MM a big flexibility to buy and sell.

By the time we do list on AIM we would have a lot more information to provide.

A lot of Positives on MDH.

MDH are in a very good place, when you look at our peers MDH are so undervalued.

If we can get regular updates and how much we are making/producing this will help,.

But the main catapult will be listing on the AIM market and this should change our valuation and bring a lot more trades, it gives so many more a chance to invest.

I added more today, the sooner we list on AIM the sooner we will get notice.

Even without buying M3 Helium, with the current Rost Well producing this will add a lot more value then what we are now.

huge trading volumes

big, long-term retail hype

multiple resource upgrades

high volatility attracts traders

strong investor brand recognition

I do hope Nick Tulloch reads the forums and see the how much more value AIM will add, this is now the time, so many helium non producers have seen a rerate and multiples of MDH's valuations.

What does it take for this share to rerate, this company has shown positive RNS's and increases in revenue.

How long until this goes and rerates.

You would have thought this share would have responded much more on the positive RNS's.

With the prescription how much money do they actually make, some of that money must go else where.

(Profit Margin: The profit comes from the difference between the cost they paid to buy the medicine (buying price) and the reimbursement price set by the NHS, plus the dispensing fees.##)

Anyone knows

If and when we list on the AIM, our valuation should go up sooner rather then later. The trades on AQSE is so little and the spread does not help.

AIM is better and different and listing should give us a lot more in value.

We do need an update on production and how much helium is being sold.

Sorry, i do recall watching an interview it was mentions the Ros well once the helium is not wasted will give $1 million per month.

Monthly helium revenue (30‑day month)

4,687.50

×

30

=

$

140,625

Monthly helium revenue: $140,625

Annual helium revenue

4,687.50

×

365

=

$

1,710,937.50

Annual helium revenue: $1.71M

This year for MDH could be massive, at present we estimate a revenue of $1.4 million per year based on MCF of 250 per day and that is with mainly the gas being sold, if they can priorities the helium split, then the 75% helium based on 250 MCF per day will work out.

Helium revenue with 75% of 250 Mcf/day

Daily helium revenue

187.5×500=$93,750" per day"

Monthly helium revenue (30-day month)

93,750×30=$2,812,500" per month"

Annual helium revenue

$2.8 million dollars per day is a lot better than $1.4 million per year.

Even if we sold 160 MCF per day this will work out $1.8 million a month, based on selling helium for $500.